Explore the exciting developments in the cannabis industry as Europe looks towards the US stock market for growth opportunities. With the US considering a more favorable stance on marijuana, European cannabis companies like Grow Group from London and Somai Pharmaceuticals from Lisbon are planning to make a splash on the Nasdaq. Discover how the booming $6.90 billion CBD market is influencing these strategic moves. While there are still federal challenges, potential changes in US marijuana classification could drive a European pivot to American exchanges. Watch to find out more about this potential shift and its implications for the cannabis and CBD industries. Don’t miss this insightful analysis for investors and enthusiasts alike!
Keywords:-
Cannabis stocks, stock market, US marijuana laws, European cannabis companies, CBD industry growth, Grow Group, Somai Pharmaceuticals, Nasdaq debut, federal hurdles, US reclassification, medicinal benefits of CBD, European shift, American exchanges, cannabis market, cannabis investment, CBD market size, US stock exchanges, cannabis business opportunities, cannabis industry news, investing in cannabis, CBD products, cannabis financial news, global cannabis market, cannabis legalization, stock market trends

source